Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Rocket Pharmaceuticals (RCKT)  
$2.88 0.05 (1.71%) as of 4:30 Mon 6/16


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 113,172,000
Market Cap: 325.94(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $2.33 - $25.88
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    : 8.7
Insider 6 Months    : 8.7
Insider 3/6 Months : 17.5
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Rocket Pharmaceuticals is a clinical-stage, multi-platform biotechnology company focused on the development of gene therapies for rare and devastating pediatric diseases. Co. has three clinical-stage ex vivo lentiviral vector. These include programs for Fanconi Anemia, a genetic defect in the bone marrow that reduces production of blood cells or promotes the production of faulty blood cells, Leukocyte Adhesion Deficiency-I, a genetic disorder that causes the immune system to malfunction, and Pyruvate Kinase Deficiency, a rare red blood cell autosomal recessive disorder that results in chronic non-spherocytic hemolytic anemia.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 41,099 41,099 41,099 41,099
Total Buy Value $200,765 $200,765 $200,765 $200,765
Total People Bought 2 2 2 2
Total Buy Transactions 2 2 2 2
Total Shares Sold 21,185 56,953 104,403 584,642
Total Sell Value $129,115 $507,361 $1,271,823 $14,189,243
Total People Sold 6 6 7 9
Total Sell Transactions 12 18 32 58
End Date 2025-03-16 2024-12-13 2024-06-14 2023-06-15

   
Records found: 174
  Page 1 of 7  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Shah Gaurav CEO   •       •      –    2025-05-20 4 S $6.45 $14,523 D/D (2,253) 786,806 57%     
   Patel Kinnari See Remarks   •       •      –    2025-05-20 4 S $6.45 $4,944 D/D (767) 441,927 57%     
   Wilson Martin General Counsel   •       •      –    2025-05-20 4 S $6.45 $3,784 D/D (587) 149,163 57%     
   Schwartz Jonathan David See Remarks   •       •      –    2025-05-20 4 S $6.45 $5,163 D/D (801) 235,255 57%     
   Militello John See Remarks   •       •      –    2025-05-20 4 S $6.45 $2,301 D/D (357) 64,027 57%     
   Patel Kinnari See Remarks   •       •      –    2025-05-16 4 S $6.53 $9,198 D/D (1,409) 442,694 55%     
   Wilson Martin General Counsel   •       •      –    2025-05-16 4 S $6.53 $6,175 D/D (946) 149,750 55%     
   Schwartz Jonathan David See Remarks   •       •      –    2025-05-16 4 S $6.53 $10,327 D/D (1,582) 236,056 55%     
   Militello John See Remarks   •       •      –    2025-05-16 4 S $6.53 $4,276 D/D (655) 64,384 55%     
   Shah Gaurav CEO   •       •      –    2025-05-16 4 S $6.53 $23,638 D/D (3,621) 789,059 55%     
   Militello John See Remarks   •       •      –    2025-04-22 4 S $7.16 $5,139 D/D (718) 65,039 58%     
   Shah Gaurav CEO   •       •      –    2025-04-10 4 B $5.08 $101,600 D/D 20,000 792,680 0.01 -41%     
   Patel Kinnari See Remarks   •       •      –    2025-04-09 4 B $4.70 $99,165 I/I 21,099 26,774 0.01 -46%     
   Ondrey Aaron Chief Financial Officer   •       •      –    2025-04-04 4 S $5.29 $39,647 D/D (7,489) 129,650 43%     
   Dolsten Mikael   •       •      –    2025-03-05 4 A $0.00 $0 D/D 14,220 14,220     -
   Schwartz Jonathan David See Remarks   •       •      –    2025-02-25 4 S $10.58 $69,109 D/D (6,532) 237,638 69%     
   Wilson Martin General Counsel   •       •      –    2025-02-21 4 S $10.58 $34,089 D/D (3,222) 150,696 72%     
   Shah Gaurav CEO   •       •      –    2025-02-21 4 S $10.58 $172,486 D/D (16,303) 772,680 72%     
   Patel Kinnari See Remarks   •       •      –    2025-02-21 4 S $10.58 $64,305 D/D (6,078) 444,103 72%     
   Militello John See Remarks   •       •      –    2025-02-21 4 S $10.58 $28,957 D/D (2,737) 65,757 72%     
   Militello John See Remarks   •       •      –    2025-02-11 4 A $0.00 $0 D/D 20,080 68,494     -
   Schwartz Jonathan David See Remarks   •       •      –    2025-02-11 4 A $0.00 $0 D/D 80,318 252,731     -
   Shah Gaurav CEO   •       •      –    2025-02-11 4 A $0.00 $0 D/D 81,655 788,983     -
   Ondrey Aaron Chief Financial Officer   •       •      –    2025-02-11 4 A $0.00 $0 D/D 90,358 137,139     -
   Wilson Martin General Counsel   •       •      –    2025-02-11 4 A $0.00 $0 D/D 90,358 153,918     -
  174 Records found
  1  2  3  4  5  6  7   
  Page 1 of 7
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us